[go: up one dir, main page]

AU2001288332A1 - Methods and compositions for modulating telomerase reverse transcriptase (tert) expression - Google Patents

Methods and compositions for modulating telomerase reverse transcriptase (tert) expression

Info

Publication number
AU2001288332A1
AU2001288332A1 AU2001288332A AU8833201A AU2001288332A1 AU 2001288332 A1 AU2001288332 A1 AU 2001288332A1 AU 2001288332 A AU2001288332 A AU 2001288332A AU 8833201 A AU8833201 A AU 8833201A AU 2001288332 A1 AU2001288332 A1 AU 2001288332A1
Authority
AU
Australia
Prior art keywords
tert
expression
compositions
methods
reverse transcriptase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001288332A
Inventor
William H. Andrews
Christopher A. Foster
Stephanie Fraser
Hamid Mohammadpour
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sierra Sciences Inc
Original Assignee
Sierra Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sierra Sciences Inc filed Critical Sierra Sciences Inc
Publication of AU2001288332A1 publication Critical patent/AU2001288332A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07—Nucleotidyltransferases (2.7.7)
    • C12Y207/07049—RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2001288332A 2000-08-24 2001-08-17 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression Abandoned AU2001288332A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22768200P 2000-08-24 2000-08-24
US22768100P 2000-08-24 2000-08-24
US60227681 2000-08-24
US60227682 2000-08-24
PCT/US2001/026039 WO2002016658A1 (en) 2000-08-24 2001-08-17 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression

Publications (1)

Publication Number Publication Date
AU2001288332A1 true AU2001288332A1 (en) 2002-03-04

Family

ID=26921657

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001288332A Abandoned AU2001288332A1 (en) 2000-08-24 2001-08-17 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression

Country Status (3)

Country Link
US (1) US20030211965A1 (en)
AU (1) AU2001288332A1 (en)
WO (1) WO2002016658A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610839B1 (en) 1997-08-14 2003-08-26 Geron Corporation Promoter for telomerase reverse transcriptase
US7378244B2 (en) * 1997-10-01 2008-05-27 Geron Corporation Telomerase promoters sequences for screening telomerase modulators
AU2002254132A1 (en) * 2001-03-06 2002-09-19 Sierra Sciences, Inc. Methods and compositions for modulating telomerase reverse transcriptase (tert) expression
US7279328B1 (en) 2002-09-30 2007-10-09 Sierra Sciences, Inc. Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
US7226744B2 (en) 2005-01-12 2007-06-05 Sierra Sciences, Inc. Assays for TERT promoter modulatory agents using a telomerase structural RNA component
GB2442001A (en) * 2006-08-11 2008-03-26 Chembiotech Nanoparticle - i-motif nucleic acid bioconjugates
US12404304B1 (en) 2007-11-14 2025-09-02 Sierra Sciences, Llc Telomerase reverse transcriptase (TERT) expression enhancing compounds and methods for using the same
US11701374B1 (en) 2010-05-18 2023-07-18 Sierra Sciences, Inc. 8-hydroxy quinoline derivatives for enhancing telomerase reverse transcriptase (TERT) expression
US9453209B2 (en) 2012-12-27 2016-09-27 Sierra Sciences, Llc Enhancing health in mammals using telomerase reverse transcriptase gene therapy
WO2014131585A1 (en) 2013-02-28 2014-09-04 Basf Se Formulations, use thereof as dishwashing detergents or for producing dishwashing detergents, and the production of said formulations
CN111544572B (en) * 2020-05-15 2022-06-07 中山大学 Application of MYDGF protein in the preparation of telomerase expression and cell senescence regulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976894A (en) * 1997-04-14 1999-11-02 Pharmacopeia, Inc. Combinatorial amide alcohol libraries
US20050032094A1 (en) * 1997-12-24 2005-02-10 Bayer Pharmaceuticals Corporation Regulatory DNA sequences of the human catalytic telomerase sub-unit gene, diagnostic and therapeutic use thereof
US6541202B1 (en) * 1999-10-13 2003-04-01 Research & Development Institute, Inc. Telomerase reverse transcriptase (TERT) genes from Candida albicans

Also Published As

Publication number Publication date
US20030211965A1 (en) 2003-11-13
WO2002016658A1 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
AU2001286540A1 (en) Methods and compositions for modulating telomerase reverse transcriptase (tert) expression
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU2001266926A1 (en) Hemostatic compositions, devices and methods
AU2002357119A1 (en) Mitocidal compositions and methods
AU2001276048A1 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
AU7429100A (en) Chondrocyte compositions, preparation and use thereof
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU2001253179A1 (en) Defoamer compositions and uses therefor
AU2001293189A1 (en) Compositions and methods for regulating apoptosis
AU2002225894A1 (en) Methods and compositions for the control of coccidiosis
AU5638999A (en) Dispersants, compositions and use
AU2001288332A1 (en) Methods and compositions for modulating telomerase reverse transcriptase (tert) expression
AU2002327178A1 (en) Methods and compositions for modulating telomerase reverse transcriptase (tert) expression
AU2002254132A1 (en) Methods and compositions for modulating telomerase reverse transcriptase (tert) expression
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2001292047A1 (en) Composition containing an azaphthalocyanine and use
AU2001241159A1 (en) Silicone gel composition
AU2002215333A1 (en) Compositions for release of radiosensitizers, and methods of making and using the same
AU4685799A (en) Telomerase inhibitors
AU2002308665A1 (en) Methods and compositions for modulating telomerase reverse transcriptase (tert) expression
AU2002256512A1 (en) Methods and compositions for modulating telomerase reverse transcriptase (tert) expression
AU2002214111A1 (en) Anti-adiposis composition based on garlic bulb extracts
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
AU4784900A (en) Polyolefin compositions using natural compound as antioxidant and/or heat-resistant
AU2001238700A1 (en) Compositions and methods of use of het, a novel modulator of estrogen action